Practical Reviews

New Staging System for Thyroid Cancer Is Slated to Become Official in January 2018

Background: The 2 most frequently used staging systems in the United States for differentiated thyroid cancer are the American Joint Committee on Cancer (AJCC) and the American Thyroid Association (ATA) risk stratification systems. The AJCC system focuses on the risk for cancer-specific mortality while ATA staging is based on risk for disease recurrence. The AJCC/TNM system is optimized to predict survival in patients with cancer. The current AJCC staging system has been used since more...
To view this content, you must be a logged in subscriber to
Please Login to view this content.